Reversing adipocyte differentiation: implications for treatment of obesity
about
Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a reviewLeptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic isletsLoss of menin mediated by endothelial cells treated with CoPP is associated with increased maturation of adipocytesLeptin induces nitric oxide-mediated inhibition of lipolysis and glyceroneogenesis in rat white adipose tissueRole of insulin and free fatty acids in the regulation of ob gene expression and plasma leptin in normal rats.Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance.Regulation of lipid and lipoprotein metabolism by PPAR activators.Leptin-specific patterns of gene expression in white adipose tissue.Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice.CREB activation induces adipogenesis in 3T3-L1 cells.PPAR alpha is necessary for the lipopenic action of hyperleptinemia on white adipose and liver tissueFat storage in adipocytes requires inactivation of leptin's paracrine activity: implications for treatment of human obesityMice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposityLeptin promotes the myofibroblastic phenotype in hepatic stellate cells by activating the hedgehog pathway.Adipogenic and antiapoptotic protein levels in human adipose stromal cells after weight loss.Peroxisome proliferator-activated receptor (PPAR) modulators: diabetes and beyond.Adipocyte apoptosis in the regulation of body fat mass by leptin.Mitochondria in the pathogenesis of lipodystrophy induced by anti-HIV antiretroviral drugs: actors or bystanders?Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.Tissue-specific 5' heterogeneity of PPARα transcripts and their differential regulation by leptin.Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1).Anti-obesity drug development.SPARC-null mice exhibit increased adiposity without significant differences in overall body weight.PPARα-Deficient ob/ob Obese Mice Become More Obese and Manifest Severe Hepatic Steatosis Due to Decreased Fatty Acid Oxidation.Comparing the hypothalamic and extrahypothalamic actions of endogenous hyperleptinemiaPref-1 (preadipocyte factor 1) activates the MEK/extracellular signal-regulated kinase pathway to inhibit adipocyte differentiation.p38 mitogen-activated protein kinase and liver X receptor-α mediate the leptin effect on sterol regulatory element binding protein-1c expression in hepatic stellate cellsDiabetes, lipids, and adipocyte secretagogues.Enhanced polyamine catabolism alters homeostatic control of white adipose tissue mass, energy expenditure, and glucose metabolism.Bilirubin Binding to PPARα Inhibits Lipid Accumulation.Is there an estrogenic component in the metabolic syndrome?New imaging techniques of fat, muscle and liver within the context of determining insulin sensitivity.Adipose-specific disruption of signal transducer and activator of transcription 3 increases body weight and adiposityThe Fto Gene Regulates the Proliferation and Differentiation of Pre-Adipocytes in VitroThe β-catenin pathway contributes to the effects of leptin on SREBP-1c expression in rat hepatic stellate cells and liver fibrosisCellular program controlling the recovery of adipose tissue mass: An in vivo imaging approach.ROCK1 reduces mitochondrial content and irisin production in muscle suppressing adipocyte browning and impairing insulin sensitivity.Lipotoxic heart disease in obese rats: implications for human obesity.Direct and indirect effects of leptin on adipocyte metabolism.Minireview: Pref-1: role in adipogenesis and mesenchymal cell fate.
P2860
Q24801508-43E2876C-859E-46B7-91CB-A1A8701E1264Q28344493-EBBFAAE1-0A21-4A93-9DC8-715D89C2AB9EQ28388738-F1216485-B634-4CC8-8E1B-09311C887250Q28574330-1BCAFA3B-F1DD-4513-9A05-5BE7FD2FB6B8Q33211418-C98A7908-4E7E-49C7-8D7D-D89797510603Q33526310-81827021-85FB-4C9D-9BDE-AF96573AE71BQ33896369-5BFF9F11-B8F6-4A87-B2D6-F8E322A63592Q33899691-5255D62E-BCC5-4F18-963F-4A71EDFD7F8FQ33954022-19CAD981-0111-47D4-8569-E87B80CFAEE1Q33961766-03C407C0-06EF-4B93-BD84-A8C8744A8D12Q34154523-7D66D6A4-2629-4DE0-A41E-196D1F363E68Q34212811-0E359372-B626-4837-9092-E8A3CBB2A84FQ34284044-B69DEB8C-7757-4D06-B97F-0CE773494866Q34299086-2509B845-BA68-4CA5-A683-C7BD1BDE7877Q34344793-21F379B1-4581-442D-BD4A-6E63D1C4FF27Q34405645-6F67A7A4-8EEC-4BF8-A197-63F474B4E022Q34434716-0AA5FEB5-4792-4702-9C1F-D2DB38476CD1Q34464649-76AF0F9F-6CF2-48A1-B836-EB5D7539FD96Q34790962-06592A7C-1C76-437F-BC0F-9CF8ABE2C231Q34794988-7EDF39AB-F687-4F88-8B71-EBD7FF5E1841Q34837133-96458C61-8A6E-4C0D-B7F3-B90BD80D62BCQ34841680-6E855240-FFA2-42F9-9773-5A8945AD1E32Q35022737-3B802050-60E0-4209-A92D-5A32FE4828ECQ35568081-961545F3-35AF-4105-A04A-F871C0A6A176Q35621402-FB790DA7-C0EF-49AF-A88E-BBF11D135419Q35676240-51F676C9-262B-4F55-BD82-218B5298402CQ35718937-C681E7E3-6718-4226-B8A0-F5D29AEC2687Q35723496-75F1A958-644D-4509-BE2D-182230C30103Q35948168-6B447879-B635-43BB-9C58-75C773AFEEB1Q35987425-8B5E0BAB-E636-4664-86F8-09092F3B273DQ36267934-EC44DC68-E385-4B93-B8B6-B656F3DB6F2BQ36378821-B08CF917-0BA0-4531-ACB3-B63C041E4322Q36513125-E981A8E2-5B28-4782-B7EE-378646D7BE08Q36633354-AF81365E-54A1-4FE7-8F37-D207474DE1F0Q36784008-89F53A7D-E982-4F0F-B2E3-52758CAB4270Q36853163-67566B35-DE5C-4BFF-95E4-C27845F224DFQ37093132-D115150C-3E79-4DC7-BB6C-355B326C0C97Q37117677-87022217-0504-4A6B-A107-300BEA5B8FEFQ37337148-93F0A44A-3514-4F93-BBB6-185A7F7DEAA1Q37418152-7CD6ADD8-3E97-4FF4-9166-2416E34AF6BB
P2860
Reversing adipocyte differentiation: implications for treatment of obesity
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Reversing adipocyte differentiation: implications for treatment of obesity
@en
Reversing adipocyte differentiation: implications for treatment of obesity.
@nl
type
label
Reversing adipocyte differentiation: implications for treatment of obesity
@en
Reversing adipocyte differentiation: implications for treatment of obesity.
@nl
prefLabel
Reversing adipocyte differentiation: implications for treatment of obesity
@en
Reversing adipocyte differentiation: implications for treatment of obesity.
@nl
P2093
P2860
P356
P1476
Reversing adipocyte differentiation: implications for treatment of obesity
@en
P2093
P2860
P304
P356
10.1073/PNAS.96.5.2391
P407
P577
1999-03-01T00:00:00Z